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Abstract
Background: Over 1.3 million people live with colorectal cancer in the United States. Physical activity is associated
with lower risk of colorectal cancer recurrence and mortality. Interventions are needed to increase physical activity
in colorectal cancer survivors.
Methods: We conducted a 2-arm non-blinded pilot randomized controlled trial at the University of California, San
Francisco among 42 individuals who had completed curative-intent treatment for colorectal cancer to determine
the feasibility and acceptability of a 12-week (84 days) physical activity intervention using a Fitbit Flex™ and daily
text messages. Participants were randomized 1:1 to receive the intervention with print educational materials or
print educational materials alone. We explored the impact of the intervention versus usual care on physical activity
using ActiGraph GT3X+ accelerometers pre−/post-intervention.
Results: We screened 406 individuals and randomized 42 to intervention (n = 21) or control (n = 21) groups. During
the 12-week study, the intervention arm wore their Fitbits a median of 74 days [88% of days in study period,
interquartile range: 23–83 days] and responded to a median of 34 (out of 46) text messages that asked for a reply
(interquartile range: 13–38 text messages). Among the 16 intervention participants who completed the feedback
survey, the majority (88%) reported that the intervention motivated them to exercise and that they were satisfied
with their experience. No statistically significant difference in change in moderate-to-vigorous physical activity was
found from baseline to 12 weeks between arms.
Conclusion: A 12-week physical activity intervention with a Fitbit and text messages was feasible and acceptable
among colorectal cancer patients after curative treatment. Larger studies are needed to determine whether the
intervention increases physical activity.
Trial registration: Clinicaltrials.gov Identifier NCT02966054. Registered 17 November 2016, retrospectively
registered.
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Background
Over 1.3 million individuals currently live with colorectal
cancer in the United States (US), representing nearly 10%
of all US cancer survivors [1]. Evidence from prospective
studies strongly suggests that physical activity after colorec-
tal cancer diagnosis reduces the risk of cancer-specific and
overall mortality [2–4]. National guidelines recommend
that cancer survivors engage in 150min per week or more
of moderate physical activity [5]. Yet, less than half of colo-
rectal cancer survivors currently meet these recommenda-
tions [6]. Interventions that increase physical activity and
ultimately improve outcomes among colorectal cancer sur-
vivors could provide a great public health benefit.
Digital health tools (e.g., text messaging, physical activity
trackers) are a promising approach for increasing physical
activity at a lower cost and burden compared to in-person
or telephone counseling. A recent systematic review con-
cluded that the majority of randomized controlled trials
(RCTs) that included text messaging reported statistically
significant improvements in health behaviors (including
physical activity) [7]. Most of this research focused on
weight loss or management of type II diabetes or cardio-
vascular disease. A growing number of digital health
behavioral interventions have included cancer patients [8],
yet colorectal cancer survivors are underrepresented in
these studies. In fact, no studies focused on colorectal can-
cer, and fewer than 30 individuals with colorectal cancer
were included in any one study that enrolled multiple
cancer types [8].
The benefits of physical activity for colorectal cancer
patients is among the most consistent association in the
epidemiologic literature of cancer survivorship, yet colo-
rectal cancer survivors are under-represented in lifestyle
intervention trials [9, 10]. The lower accrual of colorec-
tal cancer survivors may reflect their lower survival rate
(65% 5-y survival vs. 100% for prostate and 89% for
breast) as well as the disease’s distinct burden on
quality-of-life [11, 12]. Colorectal cancer patients experi-
ence unique physical and psychosocial challenges due to
their disease, such as living with an ostomy and bowel
dysfunction [12]. Consequently, the appropriate content
and format of a physical activity intervention among
colorectal cancer survivors is unknown, and may differ
compared to healthy adult populations or populations of
other cancer survivors.
Our long-term goal is to conduct a definitive random-
ized controlled trial to test the effect of a digital health
physical activity intervention on clinical outcomes among
colorectal cancer survivors. However, the feasibility and
acceptability of a digital health physical activity interven-
tion in these patients is still unknown. Therefore, we de-
veloped a digital health intervention, using a Fitbit Flex™
and daily text messages, aimed at increasing physical ac-
tivity after completion of treatment for colorectal cancer.
We conducted a 12-week pilot RCT with 42 colorectal
cancer survivors to determine the feasibility and accept-
ability of the intervention and explore the potential effect
of the intervention on accelerometer-measured physical
activity.
Methods
Study population, consent, and randomization
The University of California, San Francisco (UCSF)
Institutional Review Board approved this study. Study
data were collected and managed using REDCap elec-
tronic data capture tools hosted at UCSF [13].
The target population for this pilot RCT was individuals
with non-metastatic colon or rectal cancer who had com-
pleted curative therapy. Potentially eligible patients were
identified through the Cancer Registry at UCSF or through
recruitment in the UCSF Gastrointestinal Oncology Clinic
or Gastrointestinal Oncology Survivorship Clinic. Our ini-
tial eligibility criteria included: stage II-III colon or rectal
cancer, previous completion of cancer-directed therapy ≥3
months and < 2 years prior to enrollment, disease-free sta-
tus at enrollment, ability to speak and read English, and
ability to reliably access the internet and a mobile phone
and navigate websites. We excluded individuals with any of
19 specific contraindications to moderate-to-vigorous phys-
ical activity (MVPA; e.g., acute myocardial infarction within
six months, ongoing unstable angina, uncontrolled cardiac
arrhythmia with hemodynamic compromise, active endo-
carditis) or who were already very active at baseline (de-
fined as engaging in exercise for ≥30min for ≥5 days a
week). Due to initial slow accrual, we expanded the eligibil-
ity criteria to include patients with stage I and completely
resected stage IV disease and dropped the criteria regarding
time after completion of therapy.
We reviewed the medical records of 406 potentially eli-
gible patients (Fig. 1). Of these, 221 (54%) were ineligible,
92 declined to participate (23%), and 51 never responded
to a mailed recruitment letter (13%). The primary reasons
for ineligibility included: non-English speaking (79; 36%),
contraindications to exercise (47; 21%), and baseline phys-
ical activity ≥30min for ≥5 days a week (exceeding the
intervention goal) (41; 19%). Four patients (2%) were ex-
cluded for not having a mobile phone.
After screening, informed consent was obtained elec-
tronically from all participants included in the study. We
randomized 42 individuals who had completed curative
treatment for colon or rectal cancer. Participants were
randomized 1:1 to intervention or control using a
computer-generated randomization scheme developed
by a study biostatistician (LZ) who was blinded to group
assignment. This scheme was uploaded to REDCap, and a
clinical research coordinator utilized the randomization
tool in REDCap to obtain the group assignment for each
participant.
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Intervention development
We conducted a semi-structured, in-person, approxi-
mately 90min, group interview with three colorectal can-
cer survivors (two women and one man) who met our
study eligibility criteria to develop our text message con-
tent. The participants were 37, 49, and 52 years of age.
During the session, we asked participants about their
knowledge of physical activity recommendations for
cancer survivors, current physical activity behaviors,
barriers to physical activity, and gathered feedback on
example text messages. While we may not have ob-
tained a diversity of views or saturation of ideas from
three individuals, key suggestions from the session in-
cluded only asking for one-character responses to text
messages (e.g., Y for yes) and sending messages either
in the morning or evening so they did not arrive dur-
ing work or family time.
Intervention description
After completing the baseline assessment and randomization,
patients in the intervention arm received print educa-
tion materials on physical activity after cancer, a Fitbit
Flex™, and daily text messages [14–20]. Patients were
counseled through the print materials and text messages
to build up to 150min per week of moderate activities,
such as walking at a brisk pace, or 75min per week of vig-
orous activities, such as jogging or biking, and resistance
(strength training) exercise 2–3 times per week.
The Fitbit Flex is a popular, relatively inexpensive, and
widely available small wristband that tracks physical activ-
ity, including steps, distance, active minutes, and calories
burned. The Fitbit Flex provides a valid measure of phys-
ical activity [21]. The Fitbit Flex wirelessly synchronizes
data to a computer, tablet, or phone and provides partici-
pants with feedback through a user-friendly website. With
CONSORT Flow Diagram 
Assessed for eligibility 
(n=406) 
Not Enrolled (n=364) 
 Not meeting eligibility criteria (n=221) 
- Not English speaking (n=79) 
- Contraindication to exercise (n=47) 
- ≥150 min/wk of physical activity (n=41) 
- Not UCSF patient (n=20) 
- On treatment (n=12) 
- Not disease-free (n=9) 
- Deceased (n=8) 
- No mobile phone or Internet (n=4) 
- Incarcerated (n=1) 
 Declined (n=92) 
 No response to invitation (n=51) 
Analyzed (n=20)
Lost to follow-up1 (n=0) 
Discontinued intervention (n=0) 
Allocated to intervention (n=21) 
 Received allocated intervention (n=20)
 Did not receive intervention (n=1) 
- Diagnosed with lung cancer
Lost to follow-up1 (n=2) 
 Cancer recurrence (n=1) 
 Withdrew (n=1) 
Allocated to Control (n=21) 
 Received allocated intervention (n=21)
Analyzed (n=19) 
Randomized (n= 42)
Fig. 1 Consort Flow Diagram of a pilot randomized controlled trial of a physical activity intervention among individuals with colon or rectal
cancer. Lost to follow-up defined as not completing the 12-week accelerometer assessment
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participants’ consent, we accessed their Fitbit data at
Weeks 4, 8, and 12 of the intervention period by logging
onto their accounts and downloading their data. Partici-
pants kept their Fitbit after completion of the study.
Participants received daily text messages to their cellu-
lar phone. The text messages were based on the Theory
of Planned Behavior and results of the group interview
[14]. The message content included information about
the benefits of physical activity for colorectal cancer sur-
vivors, prompts for goal setting/planning, advice and tips
for incorporating activity into daily life, and challenges
and quizzes to increase engagement (see Additional file 1
for sample text messages). Text messages were sent once
per day in the morning (8a or 9a) or evening (6p or 8p).
Overall, the intervention took approximately 120 min
per participant for the research staff to set up and manage
over the 12-week intervention period.
Control arm
After completing the baseline assessment and randomization,
control participants received print educational mate-
rials about physical activity after cancer. We mailed
control participants a Fitbit Flex after completion of the
12-week follow-up accelerometer assessment.
Measures
Feasibility and acceptability assessment We assessed
the feasibility of the intervention through an evaluation
of adherence (e.g., Fitbit wear time, response rates to
interactive text messages) and attrition (proportion of
participants who completed the 12-week follow-up ac-
celerometer assessment). A priori, we stated that the
intervention was feasible if we were able to achieve
≥70% adherence and ≤ 20% attrition in the intervention
arm. These values were based on the reported adherence
for the CanChange trial, a telephone-delivered health be-
havior intervention in colorectal cancer survivors [22].
We assessed the acceptability of the intervention with
an investigator-developed 14-item questionnaire (see
Additional file 2) that participants in the intervention
arm completed online using REDCap [13]. Participants
were asked to what degree they agreed (strongly agree,
agree, undecided, disagree, strongly disagree) with four
statements about the text messages and one statement
about the Fitbit (e.g., “The [text messages, Fitbit] moti-
vated me to exercise.”). For the Fitbit, participants were
asked whether they accessed the Fitbit website on a com-
puter and/or via the Fitbit app on their phone; how often
they accessed the website and/or app; and whether they
would continue to wear the Fitbit after the study ended.
Participants were asked how satisfied they were overall with
the text messages and Fitbit, separately (i.e., very satisfied,
satisfied, neutral, dissatisfied, or very dissatisfied) and
provided with an open text box where they could provide
any additional feedback.
Physical activity assessment Moderate, moderate-to-
vigorous, and vigorous physical activity and daily steps
were measured at baseline and 12 weeks in both arms
using Actigraph GTX3+ accelerometers [23]. Partici-
pants wore the accelerometers around their waist for
seven consecutive days. We required at least 3 days of
valid wear time, defined as at least 10 h of wear per day
[24, 25]. We identified non-wear time using the Troiano
2007 default settings in the ActiLife v6.13.3 software.
We used the Troiano 2008 cut-points to identify average
min/d engaged in sedentary (0–99 counts per minute),
light (100–2019 counts per minute), moderate (2020–
5998 counts per minute), and vigorous physical activity
(5999 or more counts per minute) [25]. These cut-points
were chosen to facilitate comparison with NHANES
data, a nationally representative sample. For each pa-
tient, we calculated MVPA as the sum of time spent in
moderate and vigorous physical activity.
Adverse events assessment At 4, 8, and 12 weeks, par-
ticipants in both arms were asked to complete a brief
online health check-in survey to assess potential adverse
events. Participants who did not complete the online sur-
vey were first sent a reminder email and were subse-
quently called by research staff to obtain the information.
Statistical analysis
To determine if the intervention was feasible, we calcu-
lated the proportion of the intervention group who wore
their Fitbit Flex N days out of the total 84 study days
and the proportion who responded to N text messages
out of a total of 46 text messages that asked for a reply.
We compared these proportions to the nominal level
70% that we set a priori. For attrition, we calculated the
proportion of participants who completed the 12-week
accelerometer assessment, and compared that to the
nominal level 80%, which was set a priori. To describe
physical activity and estimate the effect of the interven-
tion on physical activity, we calculated each patients’
average minutes per day or steps per day based on the
7-day accelerometer at enrollment and 12-weeks. We
next calculated each patients’ change in activity levels as
the follow-up average minus baseline average, and then
for all patients in the intervention arm calculated the
mean change and for all patients in the control arm
calculated the mean change. We compared the mean
change in activity between the two groups using the
difference calculated as intervention mean change minus
control mean change and 95% confidence interval. Ana-
lyses were conducted using SAS v. 9.4.
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Results
We randomized 42 patients with colon or rectal cancer
between April 2015 – March 2017 (Fig. 1). Of these 42 ran-
domized patients, 41 participants received their assigned
intervention. One patient assigned to the intervention arm
was diagnosed with a new primary lung cancer prior to
receipt of the intervention and was withdrawn from the
study. Follow-up (based on completion and return of the
accelerometer at 12-weeks) was 95% complete in the inter-
vention arm and 90% complete in the control arm. The
two patients who did not complete the 12-week accelerom-
eter assessment in the control arm withdrew from the study
(one due to cancer recurrence and the other due to obtain-
ing her own Fitbit during the study period).
Characteristics of the intervention and control arms at
enrollment are presented in Table 1. Both groups were
more active according to the Actigraph GT3X+ accelerom-
eter data then compared to their self-reported activity dur-
ing screening. Overall, the study sample participated in 42
min per day of MVPA at enrollment. In addition, the con-
trol arm was more active (51 ± 21min per day of MVPA
and 11,830 ± 4052 steps per day) than the intervention arm
(33 ± 18min per day of MVPA and 9008 ± 3639 steps per
day) at enrollment.
The intervention was feasible and acceptable to partici-
pants. Participants randomized to the intervention arm
wore their Fitbits a median of 74 out of 84 days [88% of
study days; interquartile range (IQR): 23–83 days] (Fig. 2a).
Four participants did not wear their Fitbits (2 had 0 days
and 2 had only 1 day of wear), while five participants wore
their Fitbits every day.
While participants were overall responsive to the text
messages, the response rate decreased over time (Fig. 2b).
For example, 15/20 intervention arm participants responded
to the first text message, while only 6 responded to the last
message that asked for a response. Overall, intervention
arm participants responded to a median of 34 out of
the 46 text messages that asked for a reply (74%; IQR:
13–38 texts). One participant did not respond to any
text messages and one participant responded to every
message that asked for a reply.
Consistent with the Fitbit wear time and text message
data, participants reported that the intervention was highly
acceptable (Fig. 3). Sixteen of the 20 participants in the
Table 1 Demographic characteristics, clinical factors, and physical activity at enrollment of 41 colorectal cancer survivors in a pilot
randomized controlled trial of a physical activity intervention
Characteristic, mean ± SD or N (%) Total Intervention Control
No. of participants 41 20 21
Age, years 54 ± 11 56 ± 12 54 ± 11
Body mass index, kg/m2 28.4 ± 5.9 29.7 ± 7.2 27.1 ± 4.3
Male 17 (41) 8 (40) 9 (43)
Race
White 30 (73) 14 (70) 16 (76)
African American/Black 1 (2) 1 (5) 0 (0)
Asian 5 (12) 2 (10) 3 (14)
American Indian/Alaskan Native, Native Hawaiian or
Pacific Islander, or Other
5 (12) 3 (15) 2 (10)
College degree 38 (93) 17 (85) 21 (100)
Works full-time 26 (63) 14 (70) 12 (57)
Married 20 (49) 9 (45) 11 (52)
Cancer site
Colon 23 (56) 11 (55) 12 (57)
Rectum 18 (44) 9 (45) 9 (43)
Years since diagnosis 1.5 ± 1.5 1.8 ± 1.9 1.4 ± 1.3
Tumor Stage
I 8 (20) 4 (20) 4 (19)
II 8 (20) 2 (10) 6 (29)
III 24 (59) 13 (65) 11 (52)
IV 1 (2) 1 (5) 0 (0)
Moderate-to-vigorous physical activity, minutes/day 42 ± 21 33 ± 18 51 ± 21
Steps per day 10,453 ± 4066 9008 ± 3639 11,830 ± 4052
Van Blarigan et al. BMC Cancer          (2019) 19:218 Page 5 of 9
intervention arm completed the feedback questionnaire. Of
these, 14 (88%) agreed that the text messages motivated
them to exercise, the content of the text messages was inter-
esting to them, and the frequency of the messages (1 per
day) was ideal for them. Thirteen (81%) agreed that the tim-
ing of the text messages (morning and evening) was ideal
for them. Overall, 88% of participants were satisfied or very
satisfied with their experience with the text messages and
the Fitbit. Fourteen (88%) of the participants said that they
would continue to wear the Fitbit after the study ended.
The mean and standard deviation MVPA, moderate
physical activity, vigorous activity, and steps per day
measured by accelerometer at enrollment and 12 weeks
for participants in the intervention and control groups
are in Table 2. The intervention group engaged in a
mean of 32.9 min/d of MVPA at enrollment and 46.6
min/d of MVPA at 12-weeks. In contrast, the control
group engaged in a mean of 50.8 min/d of MVPA at en-
rollment and 54.5 min/d of MVPA at 12-weeks. On aver-
age, the intervention arm increased their MVPA by 13
min per day more than the control arm (mean differ-
ence: 13.1 min per day; 95% CI: -13.5, 39.7) (Table 2).
No serious adverse events occurred during the study.
The proportions of participants in the intervention and
controls arms who reported a priori-identified non-serious
adverse events potentially related to physical activity dur-
ing the study period are in Table 3.
Discussion
In this novel pilot RCT, we developed a feasible and accept-
able physical activity intervention for colorectal cancer sur-
vivors utilizing a physical activity tracker and daily text
messages. On average, patients randomized to the interven-
tion arm wore their Fitbit nearly 90% of the time and
responded to 74% of text messages that asked for a reply.
The vast majority of patients (88%) reported that they were
satisfied with their overall experience with the intervention.
Our study had a number of strengths. We developed
an interactive text message program to promote physical
activity in colorectal cancer survivors. In addition, we
enrolled more colorectal cancer survivors than any prior
digital health randomized controlled trial, included a
racially diverse study sample (27% minorities), and used
an accelerometer to measure physical activity at enroll-
ment and 12-weeks.
Limitations of our study included the small sample
size; the high level of physical activity, on average, that
participants performed prior to enrollment; and a
well-educated sample. We used a high cutoff for baseline
activity (i.e., 30 min or more on 5 or more days per week
based on self-report) when enrolling patients for this
pilot study in order to be more inclusive. However, this
meant that some patients did not have to change their
activity levels very much to meet the intervention goals.
Moreover, in contrast to what has been reported by
validation studies, participants’ enrollment accelerometer-
measured physical activity was even higher than their
self-reported activity during screening [26]. Given that our
participants had all volunteered for a physical activity
intervention study, we postulate that the act of wearing
the monitor motivated these individuals to exercise more
compared to their usual activity levels [27]. Future studies
should focus on less active patients; screen patients activ-
ity levels using accelerometers rather than self-report; and
consider stratifying on enrollment activity levels to ensure
balanced groups. Lastly, 93% of the participants in our
study were college educated. Future studies are needed to
determine the feasibility and acceptability of this interven-
tion in individuals with different levels of education and
socioeconomic status.
While the intervention was determined to be feasible
and acceptable, there are aspects that could be improved
in future studies. First, we applied pre-determined
cut-points for Fitbit wear and text message response rates
to assess feasibility. However, the optimal level of physical
activity tracker use (e.g., daily, several times a week) to
achieve behavior change is not known [28]. Second, we
sent daily text messages in the morning or evening based
on input from cancer survivors. However, it is not known
Fig. 2 a Number of participants who wore their Fitbit by study day.
b Number of participants who responded to each of the 46 text
messages that asked for a response
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Fig. 3 Acceptability of 12-weeks of text messages and a Fitbit Flex to individuals with colorectal cancer. 16 intervention arm participants
completed the feedback survey. All values reported are N, %
Table 2 Accelerometer-measured physical activity at enrollment and 12 weeks among 41 colorectal cancer survivors participating in
a pilot randomized controlled trial of a Fitbit Flex and daily text messages
Intervention (n = 20) Control (n = 19)a
Type of Physical Activity Baseline
Mean ± SD
12Weeks
Mean ± SD
Baseline
Mean ± SD
12Weeks
Mean ± SD
Mean difference in change in
activity between groups (95% CI)
Moderate-to-vigorous, min/day 32.9 ± 17.9 46.6 ± 48.4 50.8 ± 20.7 54.5 ± 24.9 13.1 (− 13.5, 39.7)
Moderate, min/day 32.1 ± 17.6 43.5 ± 39.0 46.9 ± 18.9 51.7 ± 23.2 9.3 (−12.8, 31.3)
Vigorous, min/day 0.87 ± 0.96 3.1 ± 10.3 3.9 ± 5.2 2.8 ± 3.3 3.8 (− 1.5, 9.1)
Steps per day 9007 ± 3638 10,047 ± 4461 11,829 ± 4052 12,541 ± 5535 649 (− 1581, 2878)
a12 week accelerometer data was not available from two participants in the control arm
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if this frequency and/or timing of messages optimizes par-
ticipants’ adherence with the intervention. In addition,
participants provided constructive feedback on ways to
improve the intervention. One participant suggested that
it would be helpful to individualize the text messages
based on what participants were recording with their
Fitbits: “someone needed to monitor this [the Fitbit data]
so other questions or prompts [via text message] could
have been given to me.” Future larger studies may be
strengthened by having real-time access to participants’
Fitbit data (versus downloading the data periodically) and
research staff available to customize messages. Lastly, par-
ticipants agreed that the Fitbit was a “great motivator,” but
one participant had trouble with the band falling off and
one participant did not like wearing it at work due to
hygiene concerns. Future studies with a larger sample size
focused on optimization of the intervention components,
including determining whether both components are
necessary for behavior change, would be of interest.
Conclusions
Overall, our pilot study demonstrated that a digital health
physical activity intervention is feasible and acceptable to
colorectal cancer survivors. A full-scale randomized con-
trolled trial to determine the effect of a digital health phys-
ical activity intervention on physical activity in colorectal
cancer survivors is warranted.
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